|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:approves
|
gptkb:2000
gptkb:FDA
|
|
gptkbp:availability
|
gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:brand
|
gptkb:Mifeprex
|
|
gptkbp:can_be_used_with
|
misoprostol
|
|
gptkbp:clinical_trial
|
Mifeprex clinical trials
|
|
gptkbp:contraindication
|
adrenal insufficiency
ectopic pregnancy
bleeding disorders
uncontrolled asthma
|
|
gptkbp:cultural_impact
|
gptkb:political_movement
gptkb:military_conflict
controversial topic
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:duration
|
up to 10 weeks gestation
|
|
gptkbp:events
|
ultrasound examination
h CG level monitoring
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mifeprex
|
|
gptkbp:impact
|
public health
healthcare costs
maternal health
unintended pregnancies
|
|
gptkbp:ingredients
|
mifepristone
|
|
gptkbp:interacts_with
|
CY P3 A4 inducers
CY P3 A4 inhibitors
|
|
gptkbp:is_involved_in
|
gptkb:philosopher
|
|
gptkbp:is_used_for
|
medical abortion
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Danco_Laboratories
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:products
|
gptkb:Plan_B
gptkb:RU-486
Cytotec
|
|
gptkbp:regulatory_compliance
|
approved for use
|
|
gptkbp:research_areas
|
reproductive health
women's rights
abortion access
|
|
gptkbp:safety_features
|
generally safe
serious complications rare
|
|
gptkbp:side_effect
|
nausea
abdominal pain
vomiting
diarrhea
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:bfsParent
|
gptkb:RU-486
|
|
gptkbp:bfsLayer
|
5
|